SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001390777-08-000046
Filing Date
2008-02-14
Accepted
2008-02-14 11:12:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 oncolytics2007yebnymc.txt SC 13G/A 38780
  Complete submission text file 0001390777-08-000046.txt   40693
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Subject) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-77907 | Film No.: 08609868
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE WALL STREET NEW YORK NY 10286
Business Address ONE WALL STREET NEW YORK NY 10286 212-495-1784
Bank of New York Mellon CORP (Filed by) CIK: 0001390777 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks